PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University, Beijing.\', \'Department of Critical Care Medicine, North China University of Science and Technology Affiliated Hospital, Tangshan.\', \'Department of Critical Care Medicine, Peking University Third Hospital, Beijing.\', \'Department of Respiratory Medicine, Qilu Hospital of Shandong University.\', \'School of Medicine, Shandong University.\', \'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan.\', \'Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000022379
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 32957417
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all